Saturday , April 27 2024
Home / Tag Archives: pfizer

Tag Archives: pfizer

Pfizer-Aktie: Soviel wert wie vor der Impfkampagne

Die Pfizer-Aktie ist wieder soviel wert, wie vor der weltweiten Impfkampagne. Und das ist interessant, zumal Pfizer die grösste Pharma-Firma der USA ist. Auf dem Höhepunkt der Impf-Kampagne musste man fast 60 US-Dollar für eine Pfizer-Aktie hinblättern. Mittlerweile notiert dieser Titel wieder unter 30 US-Dollar. Noch weniger als vor der der Impfwelle. Ein Schnäppchen? In Pfizer-Aktien kann jeder investieren, u.a. beim regulierten Broker Bitpanda. Man braucht lediglich einen verifizierten...

Read More »

Novavax (NVAX) Stock Up 8% Yesterday as FDA Approves Updated Covid Vaccine but Is 6% Down Now

The updated vaccine specifically addresses the XBB.1.5 subvariant of the Omicron variant, which has raised concerns due to its potential to evade immunity conferred by earlier versions of the vaccine.  In a recent development, stocks of Novavax Inc (NASDAQ: NVAX) jumped 8.2% yesterday following the Food and Drug Administration’s (FDA) approval of its improved COVID-19 vaccine. However, it’s worth noting that in pre-market trading, the stock experienced a slight dip and is 6% down at the...

Read More »

Google Cloud Launches Two New AI Solutions to Speed Up Drug Discovery & Precision Medicine

Google Cloud’s AI-enabled ‘Target and Lead Identification’ and ‘Multiomics’ Suites are set to improve drug discovery and precision medicine.  Google Cloud has launched two AI-powered solutions to speed up drug discovery and advance precision medicine for relevant companies. On Tuesday, the tech giant’s cloud computing suite said its newly-launched AI-powered tools would immensely help biotech and pharmaceutical companies. One of the tools, the Target and Lead Identification Suite, can...

Read More »

Merck Q1 2023 Report Shows Revenue Drop as COVID Treatment Sales Crash, MRK Stock Down 1%

Affected by reduced demand for Covid drug Molnupiravir, Merck has published reduced revenue figures according to its Q1 2023 report. Multinational pharmaceutical giant Merck & Co Inc (NYSE: MRK) has released its Q1 2023 report. The company’s figures show a reduction in revenue due to several factors, including a plunge in sales. According to published figures, Merck’s Q1 revenue is 9% lower than reported in Q1 2022. This is mainly because its Molnupiravir Covid treatment drug has seen...

Read More »

Bitcoin Spikes Following News of Potential COVID Vaccine

Early yesterday, Pfizer announced that the early phases of its new coronavirus vaccine bore positive results. The stock market has since shot up following the news, while bitcoin has also recently jumped up to the $9,400 range from $9,200.Bitcoin Is Exploded Following Vaccine HopeThe coronavirus has been one of the biggest global pandemics in recent history, as many countries throughout the world – not just some contained to a certain area or continent – have been affected. Regions of Asia,...

Read More »

Remember These Names: Moderna, BioNTech, CureVac and Keep an Eye on Their Vaccine Progress

Initiating human trials is only one step in the long process of proving the safety and efficacy of a new therapeutic. Still, the timeframes to beginning testing for Moderna, BioNTech and CureVac are faster than typical for traditional vaccines.We already wrote how almost all pharmaceutical firms throughout the whole world are doing everything to develop a vaccine that would help to stop the coronavirus spread. No matter if they’re big or small, the goal is the same and it is no more just a...

Read More »

Alphabet (GOOGL) Stock Is in Red But It Looks Bullish in the Long Term

In the very recent past, Alphabet (GOOGL) stock has plunged a bit. However, the general trajectory and report of the company look quite positive.With a market cap over $1 trillion, Alphabet Inc. (NASDAQ: GOOGL) stock is a top tech stock and one of the world’s most valuable companies. All of the different facets of large tech companies like these make them very attractive to investors and also keeps them soaring higher. Regardless, even some of the biggest falter, as market factors do not...

Read More »

Pfizer Corporation Experiences Profit Cut, Won’t Repurchase Own Stocks in 2020

The price of Pfizer stocks fell 4% down to $38.51 during Q4 2019. During the last year, the company bought back approximately $9 billion in its stocks to foster market growth. However, the largest medicine giant is losing money and wants its Upjohn development to merge with Mylan NV, which is another big drugmaker aiming at new types of medications.The Upjohn is selling the drugs that lost patent protection, such as Viagra and Lyrica. By the middle of 2020, the company management will...

Read More »